SAN DIEGO, CA / ACCESSWIRE / November 23, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, the Company's Chief Executive Officer, will be participating in the following investor conferences:
Piper Sandler 34th Annual Healthcare Conference at the Lotte New York Palace Hotel in New York City: Mr. Besser will make a corporate presentation on November 30, 2022, beginning at 10:50 a.m. ET. In addition, Mr. Besser will host one-on-one meetings on November 30, 2022. To schedule a one-on-one meeting, please contact your Piper Sandler representative.
Benchmark Company's 11th Annual Discovery Investor Conference at the New York Athletic Club in New York City: Mr. Besser will host one-on-one meetings with investors on December 1, 2022. To schedule a one-on-one meeting, attendees should submit a request online via the link provided upon registration. To attend the conference, please register at: https://www.benchmarkcompany.com/news-events/upcoming-events/the-11th-annual-discovery-one-on-one-investor-conference
About Modular Medical, Inc.
Modular Medical, Inc. (NASDAQ:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Our mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding MODD, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
All trademarks mentioned herein are the property of their respective owners.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$0.58 |
Daily Change: | -0.04 -5.81 |
Daily Volume: | 726,086 |
Market Cap: | US$32.000M |
September 29, 2025 September 15, 2025 September 11, 2025 August 26, 2025 August 08, 2025 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load